Cargando…
The fear of cancer recurrence and progression in patients with pancreatic cancer
PURPOSE: It is plausible that patients with pancreatic cancer experience fear of tumor recurrence or progression (FOP). The aim of this study was to compare FOP in patients with pancreatic cancer treated with surgical resection, palliative systemic treatment, or best supportive care (BSC) and analyz...
Autores principales: | Pijnappel, Esther N., Dijksterhuis, Willemieke P. M., Sprangers, Mirjam A. G., Augustinus, Simone, de Vos-Geelen, Judith, de Hingh, Ignace H. J. T., Molenaar, Izaak Q., Busch, Olivier R., Besselink, Marc G., Wilmink, Johanna W., van Laarhoven, Hanneke W. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046341/ https://www.ncbi.nlm.nih.gov/pubmed/35169873 http://dx.doi.org/10.1007/s00520-022-06887-w |
Ejemplares similares
-
Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort study
por: Latenstein, Anouk E. J., et al.
Publicado: (2020) -
Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide Study
por: Pijnappel, Esther N., et al.
Publicado: (2022) -
Delayed Versus Immediate Start of Chemotherapy in Asymptomatic Patients With Advanced Cancer: A Meta-Analysis
por: Augustinus, Simone, et al.
Publicado: (2023) -
FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study
por: Rombouts, SJ, et al.
Publicado: (2016) -
Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study
por: Dijksterhuis, Willemieke P.M., et al.
Publicado: (2019)